🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,39 USD

Máx. histórico

119,27

4269 días

Caída desde máximo

-69,49%

Rango 52 semanas

18,80 – 36,67

Variación hoy

-0,03%

Cierre anterior

36,40

Rango de hoy

36,39 – 36,41

Volumen hoy

1.075.323

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,36%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
103,97 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 13 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/02/2024 31,08 31,15 30,14 30,34 -4,53% 3,25% 1.217.500
01/02/2024 32,65 32,65 31,70 31,78 -2,49% 2,91% 550.000
31/01/2024 33,06 34,01 32,49 32,59 -1,45% 4,60% 584.800
30/01/2024 33,64 33,64 32,35 33,07 +1,85% 3,83% 554.300
29/01/2024 32,02 32,82 31,50 32,47 +1,31% 4,12% 375.700
26/01/2024 32,67 32,77 32,03 32,05 -1,05% 2,27% 267.500
25/01/2024 32,63 32,84 31,96 32,39 +0,65% 2,70% 259.500
24/01/2024 32,78 32,96 31,63 32,18 -0,68% 4,06% 291.300
23/01/2024 32,71 32,96 31,82 32,40 +0,31% 3,49% 262.700
22/01/2024 32,13 32,85 31,76 32,30 +1,44% 3,39% 390.700
19/01/2024 31,79 31,89 31,10 31,84 +0,35% 2,49% 306.500
18/01/2024 31,85 32,07 31,41 31,73 +0,28% 2,07% 414.900
17/01/2024 31,86 32,20 31,20 31,64 -2,13% 3,14% 390.100
16/01/2024 32,25 32,51 31,58 32,33 +0,31% 2,88% 385.600
12/01/2024 33,01 33,01 32,03 32,23 -1,29% 2,97% 344.200
11/01/2024 32,94 32,94 31,00 32,65 -1,57% 5,89% 848.000
10/01/2024 34,78 34,78 32,87 33,17 -4,49% 5,49% 616.200
09/01/2024 35,31 35,81 34,02 34,73 -2,11% 5,07% 465.600
08/01/2024 34,29 35,95 34,15 35,48 +3,53% 5,25% 691.900
05/01/2024 32,24 34,86 32,11 34,27 +5,71% 8,53% 599.600
04/01/2024 32,15 32,61 31,56 32,42 +1,09% 3,27% 381.400
03/01/2024 32,19 32,53 31,34 32,07 +0,22% 3,70% 480.400
02/01/2024 33,48 33,72 31,97 32,00 -5,16% 5,23% 679.600
29/12/2023 33,50 33,79 32,92 33,74 +0,48% 2,60% 419.700
28/12/2023 34,14 34,52 33,45 33,58 -2,13% 3,13% 484.400
27/12/2023 33,75 34,43 33,69 34,31 +2,05% 2,19% 508.500
26/12/2023 33,26 33,78 33,21 33,62 +1,72% 1,71% 359.600
22/12/2023 33,17 33,71 32,55 33,05 +0,24% 3,50% 400.400
21/12/2023 32,24 33,37 32,20 32,97 +2,36% 3,63% 630.000
20/12/2023 32,16 33,39 31,94 32,21 +2,35% 4,51% 751.100